Article List

WPRIM Management System> DCMS> Korean Journal of Psychopharmacology> 2007> 18

Volume: 18

1. Risperidone Combination in the Acute Treatment of Bipolar Mania and Mixed Episode: Prospective, Multicenter, Open Trial.	Page:318—328
2. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(II): Initial Treatment and Treatment Resistant OCD.	Page:347—357
3. Assessment of Abdominal Fat and Mid-Thigh Low-Density Muscle Areas in Patients with Schizophrenia.	Page:81—85
4. Two-Year Rehospitalization Rates of First Episode Schizophrenic Inpatients Discharged on Antipsychotic Medication : A Preliminary Study.	Page:86—91
5. Body Weight Gain and Metabolic Changes in Patients with Schizophrenia during 12-Week Randomized Treatment of Ziprasidone and Risperidone.	Page:92—102
6. Body Mass Index(BMI) Changes during Combination Therapy with Mood Stabilizers and Antipsychotics in Acute Mania.	Page:103—109
7. Hyponatremia with Neurological Symptom in Patients with Chronic Schizophrenia : Five Cases.	Page:110—117
8. Comparison of the Clinical Efficacy and Safety between Intramuscular Olanzapine and Intramuscular Haloperidol Injection in the Treatment of Delirium.	Page:423—428
9. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(IV): Comorbid Conditions.	Page:414—422
10. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(III): A Preliminary Study for Application of Cognitive-Behavioral Therapy.	Page:408—413
11. The Implication of Incrementally Modified Drug Technology and the Current Trends in Psychopharmacology.	Page:373—383
12. Atypical Antipsychotics in Bipolar Depression: Neurobiological Mechanisms and Application to Treatment.	Page:384—392
13. Common Gene Expression Pattern in the Rat Brain Induced by Several Mood: Stabilizing Drugs.	Page:211—220
14. Brain Mapping for Memory and Learning.	Page:199—210
15. A Case of Single Photon Emission Computerized Tomographic Finding in Patient with Acquired Deafness and Musical Hallucinosis after Viral Encephalitis.	Page:60—64
16. Prescription Status and Efficacy of OROS-MPH and Parent Perception in Children with Attention Deficit Hyperactivity Disorder : Multi-Center, Observational Study during 4 Weeks.	Page:50—59
17. Multicenter Clinical Trials for Efficacy and Safety of Mirtazapine in Moderate-to-Severe Major Depressive Patients.	Page:36—49
18. Do SSRIs Really Induce Suicidal Behavior? : The Critical Review of Evidences.	Page:25—35
19. Intravenous Anti-obsessive Agents : A Review.	Page:18—24
20. Korean Traditional Medicines as Novel Drugs for Neuropsychiatric Disorders.	Page:5—17
21. Maintenance Period of Venlafaxine ER Treatment in Patients Having Major Depressive Disorder with Somatic Symptoms.	Page:329—337
22. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007 (I).	Page:338—346
23. Comparison of the Clinical Efficacy and Safety between Intramuscular Olanzapine and Intramuscular Haloperidol Injection in the Treatment of Delirium.	Page:423—428
24. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(IV): Comorbid Conditions.	Page:414—422
25. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(III): A Preliminary Study for Application of Cognitive-Behavioral Therapy.	Page:408—413
26. Changes of Medication Usage in Inpatients with Major Depressive Disorder: One University Hospital between Year 2001 and 2006.	Page:399—407
27. Changes of Medication Usage in Inpatients with Major Depressive Disorder: One University Hospital between Year 2001 and 2006.	Page:399—407
28. The Association between Smoking and Depression.	Page:393—398
29. The Association between Smoking and Depression.	Page:393—398
30. Atypical Antipsychotics in Bipolar Depression: Neurobiological Mechanisms and Application to Treatment.	Page:384—392
31. The Implication of Incrementally Modified Drug Technology and the Current Trends in Psychopharmacology.	Page:373—383
32. Ziprasidone Induced Neutropenia.	Page:251—255
33. Elevation of Serum Creatine Kinase Level in a Patient Treated with Atypical Antipsychotics: A Case Report.	Page:246—250
34. Comparison of Efficacy between Aripiprazole and Haloperidol in the Treatment of Patients with Delirium.	Page:240—245
35. Remission Rates and Criteria for Clinical Studies on Schizophrenia.	Page:231—239
36. Clinical Efficacy and Safety of Memantine in Patients with Moderate to Severe Dementia.	Page:163—170
37. A Validation Study of the Korean Version of the Subjective Well-being Under Neuroleptic Treatment Scale-Short Form.	Page:221—230
38. Neuroanatomy of Sleep-Wake Regulation and its Application to Pharmacotherapy.	Page:133—142
39. Recent 5-Year Trends of Prescription Patterns in Inpatients with Bipolar Disorder in Four Hospitals.	Page:308—317
40. The Relationship between the Antipsychotics-Induced Weight Gain and the Dopamine D2, D3, and D4 Receptor Gene Polymorphisms in Korean Schizophrenic Patients.	Page:299—307
41. Effects of Haloperidol on Ca2+i Change in HIT T-15 Insulinoma Cells.	Page:288—298
42. Neurokinin and Its Receptors: Association with Learning and Memory.	Page:280—287
43. Role of 5-HT1A Receptors in Learning and Memory.	Page:271—279
44. Rhabdomyolysis Associated with Ziprasidone.	Page:181—184
45. Treatment of Persistent Hiccups with Risperidone Quicklet.	Page:177—180
46. A Case of Aggressive and Violent Patient with Treatment-Resistant Schizophrenia Treated with Long-Acting Injectable Risperidone.	Page:171—176
47. The Subjective Effect of Quetiapine Monotherapy on Sleep and Daytime Sleepiness in Acute Manic Patient.	Page:152—162
48. Association of BDNF Val66Met Polymorphism with Depressive and Cognitive Symptoms in Patients with Schizophrenia.	Page:143—151